Literature DB >> 8885870

An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene.

J L Rinkenberger1, J J Wallin, K W Johnson, M E Koshland.   

Abstract

Cytokine regulation of B cell development was analyzed using interleukin-2 (IL-2)-induced transcription of the J chain gene as a model system. A nuclear target of the IL-2 signal was identified as the Pax5 transcription factor, BSAP, which recognizes a negative regulatory motif in the J chain promoter. Functional assays showed that BSAP mediates the silencing of the J chain gene during the early stages of B cell development, but repression is relieved during the antigen-driven stages in a concentration-dependent manner by an IL-2-induced down-regulation of BSAP RNA expression. At the low levels present in J chain-expressing plasma cells, BSAP repression could be overridden by positive-acting factors binding to down-stream J chain promoter elements. Overexpression of BSAP in these cells reversed the positive regulation and inhibited J chain gene transcription. Thus, IL-2 regulation of BSAP concentration may provide a mechanism for controlling both repressor and activator functions of BSAP during a B cell immune response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8885870     DOI: 10.1016/s1074-7613(00)80263-0

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  29 in total

1.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Noncoordinate expression of J-chain and Blimp-1 define nurse shark plasma cell populations during ontogeny.

Authors:  Caitlin D Castro; Yuko Ohta; Helen Dooley; Martin F Flajnik
Journal:  Eur J Immunol       Date:  2013-08-27       Impact factor: 5.532

Review 3.  Cellular and chromatin dynamics of antibody-secreting plasma cells.

Authors:  Alexandra Bortnick; Cornelis Murre
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-10-21       Impact factor: 5.814

Review 4.  Expansion or depletion of T follicular helper cells during HIV infection: consequences for B cell responses.

Authors:  Olusegun O Onabajo; Joseph J Mattapallil
Journal:  Curr HIV Res       Date:  2013-12       Impact factor: 1.581

5.  Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines.

Authors:  J Lauring; M S Schlissel
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

6.  Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.

Authors:  Dina Schneider; Maria A Manzan; Byung Sun Yoo; Robert B Crawford; Norbert Kaminski
Journal:  Toxicol Sci       Date:  2009-02-23       Impact factor: 4.849

7.  The Blimp-1 gene regulatory region directs EGFP expression in multiple hematopoietic lineages and testis in mice.

Authors:  Dingyan Wang; Lihua Zhuang; Bo Gao; Chang-Xin Shi; Joseph Cheung; Mingyao Liu; Tianru Jin; Xiao-Yan Wen
Journal:  Transgenic Res       Date:  2007-09-19       Impact factor: 2.788

8.  2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.

Authors:  Dina Schneider; Maria A Manzan; Robert B Crawford; Weimin Chen; Norbert E Kaminski
Journal:  J Pharmacol Exp Ther       Date:  2008-05-15       Impact factor: 4.030

9.  Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients.

Authors:  Nicolle Helena Renier Litjens; Martin Huisman; Marinus van den Dorpel; Michiel Gerardus Henricus Betjes
Journal:  J Am Soc Nephrol       Date:  2008-05-14       Impact factor: 10.121

10.  Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells.

Authors:  Kuo-I Lin; Cristina Angelin-Duclos; Tracy C Kuo; Kathryn Calame
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.